Congenital toxoplasmosis.
Olliaro
Piero
P
UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases CDS/CRD/World Health Organization, Geneva, Switzerland.
D003049:Coccidiostats / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000188:drug therapy* / Q000517:prevention & control; D012307:Risk Factors; D015572:Spiramycin / Q000009:adverse effects / Q000627:therapeutic use; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy* / Q000517:prevention & control
D003049:Coccidiostats; D015572:Spiramycin